drug discovery, done right
small molecules, global reach
What We Do
We are experts in the research and production of small molecules for the pharmaceutical industry. We also have a 40-year legacy of research and development, the most promising of which forms our drug discovery pipeline.
Our Mission
Changing the face of disease through the accelerated advancement of our pipeline
Press Releases
Edmonton’s General Intermediates of Canada Inc. (GIC) announced today that they have received conditional funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) related to their discovery ...
Edmonton’s General Intermediates of Canada Inc. (GIC) announced today that they have successfully completed a research project related to a key starting API material for a global ...
- ANNOUNCED TODAY:
GIC has received government funding for our immuno-oncology project!
Details here:… https://t.co/bJdv1ZSjma
21 Aug 2018 - RT @ZealAccess: Congrats to @GIC_News on getting govt funding for their immuno-oncology project https://t.co/RtOLqQVfHb #biotech #canadabio
21 Aug 2018
